ConductScience.org, home

Paper41226440

The Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research.

Grigoreva TA and 4 others. Int J Mol Sci, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. The Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research. Papers, record 41226440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41226440

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grigoreva TATatyana Ahttps://orcid.org/0000-0003-1271-0328
2Kindt DNDaria Nhttps://orcid.org/0000-0002-0181-4968
3Sagaidak AVAleksandra Vhttps://orcid.org/0000-0001-6280-1979
4Romanova AAAngelina Ahttps://orcid.org/0000-0002-0290-1668
5Tribulovich VGVyacheslav Ghttps://orcid.org/0000-0001-7723-4962

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, NeoplasmMajor topic
NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Humans
Cell Line, Tumor
Animals

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
23-13-00344Russian Science FoundationPubMed

Source PubMed

Download CSV of grants

References153

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19137537Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP.Cancer Chemother Pharmacol1997https://conductscience.org/library/papers/9137537PubMed
236224343Molecular targeted therapy for anticancer treatment.Exp Mol Med2022https://conductscience.org/library/papers/36224343PubMed
338154263Mechanical effects modulate drug resistance in MCF-7-derived organoids: Insights into the wnt/β-catenin pathway.Biochem Biophys Res Commun2024https://conductscience.org/library/papers/38154263PubMed
425760096Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.Mol Med Rep2015https://conductscience.org/library/papers/25760096PubMed
538608058A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer.Medicine (Baltimore)2024https://conductscience.org/library/papers/38608058PubMed
639175042Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib).Cell Commun Signal2024https://conductscience.org/library/papers/39175042PubMed
722179686Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines.Int J Oncol2012https://conductscience.org/library/papers/22179686PubMed
838381934Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.Br J Surg2024https://conductscience.org/library/papers/38381934PubMed
9348300823D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages.Int J Mol Sci2021https://conductscience.org/library/papers/34830082PubMed
1033046798Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.Oncogene2020https://conductscience.org/library/papers/33046798PubMed
1130031797Molecular targeted therapy: Treating cancer with specificity.Eur J Pharmacol2018https://conductscience.org/library/papers/30031797PubMed
1232486365Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32486365PubMed
1329410625Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.Front Pharmacol2018https://conductscience.org/library/papers/29410625PubMed
1438737455Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance.Cell Mol Bioeng2024https://conductscience.org/library/papers/38737455PubMed
1524126575Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line.Int J Oncol2013https://conductscience.org/library/papers/24126575PubMed
1631133756Mitochondrial metabolism promotes adaptation to proteotoxic stress.Nat Chem Biol2019https://conductscience.org/library/papers/31133756PubMed
1720512087The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2.Med Sci Monit2010https://conductscience.org/library/papers/20512087PubMed
1838572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1925566959Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.Tumour Biol2015https://conductscience.org/library/papers/25566959PubMed
2021150160Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line.Gynecol Obstet Invest2011https://conductscience.org/library/papers/21150160PubMed

See all 153 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42595339Polyphyllin I Orchestrates Autophagy to Reprogram the Tumour Immune Microenvironment and Abrogate Cisplatin Resistance in Non-Small Cell Lung Cancer.Clin Exp Pharmacol Physiol2026https://conductscience.org/library/papers/42595339

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41226440

GET https://conductscience.org/api/papers/v1/41226440/references?page=2